Udo Kellner

1.6k total citations
47 papers, 1.2k citations indexed

About

Udo Kellner is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Udo Kellner has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Surgery. Recurrent topics in Udo Kellner's work include Cancer therapeutics and mechanisms (5 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Udo Kellner is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Udo Kellner collaborates with scholars based in Germany, United States and United Kingdom. Udo Kellner's co-authors include Albert Roessner, Pierre Rudolph, Reza Parwaresch, Frank Gieseler, Maxwell Sehested, Peter Buhl Jensen, Sabine Krueger, P. Rudolph, René Bernards and Iris Simón and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Udo Kellner

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Udo Kellner Germany 20 636 445 343 232 135 47 1.2k
Emmanuel Blot France 19 543 0.9× 639 1.4× 368 1.1× 207 0.9× 113 0.8× 50 1.4k
Andrew Redfern Australia 20 732 1.2× 703 1.6× 439 1.3× 262 1.1× 104 0.8× 102 1.6k
Carmen Pacilio Italy 21 509 0.8× 637 1.4× 251 0.7× 318 1.4× 89 0.7× 47 1.2k
Gudrun Pohl Austria 19 661 1.0× 579 1.3× 237 0.7× 150 0.6× 141 1.0× 35 1.4k
Anna Maria Aglianò Italy 22 486 0.8× 654 1.5× 330 1.0× 185 0.8× 250 1.9× 43 1.3k
James Russell United States 20 623 1.0× 396 0.9× 483 1.4× 213 0.9× 85 0.6× 45 1.4k
Yingfen Wu China 12 844 1.3× 361 0.8× 616 1.8× 180 0.8× 112 0.8× 12 1.3k
Claude Allasia France 26 875 1.4× 718 1.6× 527 1.5× 180 0.8× 107 0.8× 58 1.9k
Aaron C. Spalding United States 21 565 0.9× 341 0.8× 323 0.9× 221 1.0× 195 1.4× 41 1.3k
Donna Badgwell United States 13 597 0.9× 267 0.6× 325 0.9× 112 0.5× 199 1.5× 18 1.5k

Countries citing papers authored by Udo Kellner

Since Specialization
Citations

This map shows the geographic impact of Udo Kellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Kellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Kellner more than expected).

Fields of papers citing papers by Udo Kellner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udo Kellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Kellner. The network helps show where Udo Kellner may publish in the future.

Co-authorship network of co-authors of Udo Kellner

This figure shows the co-authorship network connecting the top 25 collaborators of Udo Kellner. A scholar is included among the top collaborators of Udo Kellner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udo Kellner. Udo Kellner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niehaus, Karsten, Felix Bremmer, Ulrich Krafft, et al.. (2021). A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer. Laboratory Investigation. 101(9). 1281–1288. 12 indexed citations
2.
Hagel, Christian, Ulrich Schüller, Jörg Flitsch, et al.. (2021). Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles. Pituitary. 24(6). 904–913. 10 indexed citations
3.
Faust, Isabel, Jan Weile, Buntaro Fujita, et al.. (2019). Heart Transplantation in Systemic Sclerosis: New Impulses for Conventional Scleroderma Transplantation Regimen and Scleroderma Diagnostic Monitoring: 2 Case Reports. Transplantation Proceedings. 51(3). 865–870. 10 indexed citations
4.
Vollbrecht, Claudia, Dido Lenze, Michael Hummel, et al.. (2018). RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance. BMC Cancer. 18(1). 1158–1158. 17 indexed citations
5.
Schiefer, Ana‐Iris, Ildikó Mesteri, Oskar Koperek, et al.. (2016). Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues. Journal of Molecular Diagnostics. 18(3). 370–377. 26 indexed citations
6.
Sargent, Daniel J., Qian Shi, Sharlene Gill, et al.. (2014). Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study. Clinical Cancer Research. 20(16). 4361–4369. 8 indexed citations
7.
Brunen, Diede, Stefan M. Willems, Udo Kellner, et al.. (2013). TGF-β: An emerging player in drug resistance. Cell Cycle. 12(18). 2960–2968. 108 indexed citations
8.
Lage, Hermann & Udo Kellner. (2013). Resistenzen gegenüber medikamentöser Tumortherapie. Der Pathologe. 34(5). 398–402. 1 indexed citations
9.
Gessi, Marco, K. Kuchelmeister, Udo Kellner, et al.. (2012). Unusual clinico-pathological features in primary Hodgkin’s lymphomas of the central nervous system. Acta Neurochirurgica. 155(1). 19–24. 8 indexed citations
10.
Schulz, Hans‐Ulrich, et al.. (2008). Ektopes Pankreasgewebe im Duodenum – mögliche Begleitursache für symptomatische chronische Pankreatitis. Visceral Medicine. 24(4). 309–312.
11.
Krueger, Sabine, Thomas Kalinski, Thomas Wex, et al.. (2005). Up‐regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. The Journal of Pathology. 207(1). 32–42. 84 indexed citations
12.
Nägler, Dorit K., Sabine Krüger, Edmund Ziomek, et al.. (2004). Up‐regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. The Prostate. 60(2). 109–119. 68 indexed citations
13.
Juhász, Márk, Uwe Lendeckel, Udo Kellner, et al.. (2003). Expression of carbonic anhydrase IX in human pancreatic cancer. Alimentary Pharmacology & Therapeutics. 18(8). 837–846. 48 indexed citations
14.
15.
Kellner, Udo, Maxwell Sehested, Peter Buhl Jensen, Frank Gieseler, & Pierre Rudolph. (2002). Culprit and victim – DNA topoisomerase II. The Lancet Oncology. 3(4). 235–243. 138 indexed citations
16.
Krueger, Sabine, et al.. (2001). Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotype. Cancer Gene Therapy. 8(7). 522–528. 51 indexed citations
17.
Miettinen, Helena E., Tero A.H. Järvinen, Udo Kellner, et al.. (2000). High topoisomerase IIα expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas. Neuropathology and Applied Neurobiology. 26(6). 504–512. 37 indexed citations
18.
Kellner, Udo, Holger A. Haenssle, Pierre Rudolph, & Reza Parwaresch. (2000). Detection of four new single-stranded telomeric DNA binding proteins by means of an optimized protein blotting procedure. Pathology - Research and Practice. 196(12). 801–806. 2 indexed citations
19.
Kellner, Udo, P. Rudolph, & Reza Parwaresch. (2000). Human DNA-Topoisomerases – Diagnostic and Therapeutic Implications for Cancer. Oncology Research and Treatment. 23(5). 424–430. 39 indexed citations
20.
Kellner, Udo & J. Esser. (1989). Akute Psychose durch Intoxikation mit Cyclopentolat. Klinische Monatsblätter für Augenheilkunde. 194(6). 458–461. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Blot Breakdown of academic impact, for papers by Andrew Redfern Breakdown of academic impact, for papers by Carmen Pacilio Breakdown of academic impact, for papers by Gudrun Pohl Breakdown of academic impact, for papers by Anna Maria Aglianò Breakdown of academic impact, for papers by James Russell Breakdown of academic impact, for papers by Yingfen Wu Breakdown of academic impact, for papers by Claude Allasia Breakdown of academic impact, for papers by Aaron C. Spalding Breakdown of academic impact, for papers by Donna Badgwell
Rankless by CCL
2026